ArticleJournal of behavioral medicine2025
Associations between self-reported and actigraphy measured sleep duration with metabolic syndrome: evidence from NHANES 2011-2014.
Article in Journal of behavioral medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We used a nationally representative dataset to examine the associations between self-reported and actigraphy-measured sleep duration and a continuous metabolic syndrome (MetS) severity score in the United States population. We analyzed cross-sectional data from the national and nutrition examination survey (NHANES) 2011-2014 cycles. Our sample included adults (≥ 20 years) with complete data on sleep, sociodemographic, and MetS-related variables (N = 3245). A composite MetS severity score (MetSSS) was created using measures of waist circumference, fasting glucose, blood pressure, HDL cholesterol, and triglycerides. Actigraphy-measured sleep duration was obtained from accelerometer data collected across 7 days. Self-reported sleep duration was obtained using a one-time single question. The association between sleep duration and MetSSS was examined using linear regression models adjusting for relevant confounders. Self-reported short sleep duration (but not long), and actigraphy-measured long sleep duration (but not short) predicted greater MetSSS (b = 0.21, p < .001 and b = 0.33, p < .001, respectively), when adjusting for sociodemographic factors (age, sex, race/ethnicity, education, income, food insecurity, and health insurance status). However, after covarying for depression, sedentary behavior, sleep disturbances, and diet, only actigraphy measured long sleep duration remained significantly associated with MetS. Both short and long sleep duration may increase the severity of metabolic syndrome. However, the association between short sleep duration and metabolic syndrome may be confounded by other variables (e.g., health behaviors, sleep quality, mood). Research and clinical implications of these results are discussed.
Indexed as
Identifiers
40830713What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.